Handelsbanken Fonder’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Handelsbanken Fonder’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-18,500	Closed	-$756K	–	1534
2024 Q2	$756K	Buy	18,500 +2,300	+14%	+$95.8K	﹤0.01%	963
2024 Q1	$685K	Hold	16,200	–	–	﹤0.01%	1015
2023 Q4	$687K	Buy	16,200 +4,600	+40%	+$132K	﹤0.01%	968
2023 Q3	$253K	Hold	11,600	–	–	﹤0.01%	1372
2023 Q2	$369K	Buy	11,600 +2,600	+29%	+$79.8K	﹤0.01%	1238
2023 Q1	$220K	Hold	9,000	–	–	﹤0.01%	1426
2022 Q4	$284K	Hold	9,000	–	–	﹤0.01%	1281
2022 Q3	$254K	Buy	9,000 +300	+3%	+$8.94K	﹤0.01%	1338
2022 Q2	$230K	Sell	8,700 -1,600	-16%	-$45.4K	﹤0.01%	1450
2022 Q1	$361K	Hold	10,300	–	–	﹤0.01%	1411
2021 Q4	$334K	Buy	+10,300	New	+$363K	﹤0.01%	1577

Other funds holding CERE

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Handelsbanken Fonder's CERE Position: Q3 2024 in Review

Handelsbanken Fonder sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 18,500 shares — an estimated $756K sold.

Handelsbanken Fonder first reported a position in CERE in Q4 2021 and held it in 11 quarters. The position peaked at $756K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

Handelsbanken Fonder reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Handelsbanken Fonder sold 18,500 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $756K.
Handelsbanken Fonder first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2021 and held it in 11 quarters.
Handelsbanken Fonder's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $756K in Q2 2024.
2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.